These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32567594)

  • 1. Treatment and outcome in 12 cases of olfactory neuroblastoma at Mexico´s National Cancer Institute: A retrospective clinical analysis and literature review.
    Navarro-Fernández JO; Serrato-Avila JL; Hernández-Varela M; Tejada-Pineda MF; Hernández-Reséndiz RE; Monroy-Sosa A; Cacho-Díaz B; Herrera-Gómez Á; Reyes-Soto G
    Cir Cir; 2020; 88(4):453-460. PubMed ID: 32567594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of recurrence and disease progression in patients with positive-margin olfactory neuroblastoma following primary resection.
    Bauman MMJ; Graves JP; Haller TJ; McMillan RA; Routman DM; Raghunathan A; Stokken JK; Link MJ; Moore EJ; Choby G; Van Gompel JJ
    J Neurosurg; 2024 Sep; 141(3):711-719. PubMed ID: 38518294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
    Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
    Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retained role of surgery for olfactory neuroblastoma.
    Smee RI; Broadley K; Williams JR; Meagher NS; Bridger GP
    Head Neck; 2011 Oct; 33(10):1486-92. PubMed ID: 21928422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
    Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
    Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
    Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb.
    Mays AC; Bell D; Ferrarotto R; Phan J; Roberts D; Fuller CD; Frank SJ; Raza SM; Kupferman ME; DeMonte F; Hanna EY; Su SY
    Laryngoscope; 2018 Jun; 128(6):1274-1280. PubMed ID: 29226334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
    Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
    APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Analysis and Prognostic Factors After Endonasal Resection of Advanced Olfactory Neuroblastomas: A Single Institution Experience.
    Song X; Yang J; Yuan C; Gu D; Wang L; Zhang Q; Zhou C; Wang H; Hu L; Zhang C; Liu Q; Wang D; Sun X; Yu H
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241267737. PubMed ID: 39164943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
    Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
    Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esthesioneuroblastoma chemotherapy and radiotherapy for extensive disease: a case report.
    Gupta S; Husain N; Sundar S
    World J Surg Oncol; 2011 Oct; 9():118. PubMed ID: 21974776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
    Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
    PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic Endonasal Management of Olfactory Neuroblastoma: A Retrospective Analysis of 10 Patients with Quality-of-Life Measures.
    Manthuruthil C; Lewis J; McLean C; Batra PS; Barnett SL
    World Neurosurg; 2016 Jun; 90():1-5. PubMed ID: 26899467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence morbidity of olfactory neuroblastoma.
    Melder K; Mace JC; Choby G; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Fung NK; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; Patel C; Patel Z; Celda MP; Pinheiro-Neto CD; Snyderman C; Thorp BD; Van Gompel JJ; Zenonos G; Zwagerman NT; Sanusi O; Wang EW; Geltzeiler M
    Int Forum Allergy Rhinol; 2024 Sep; 14(9):1435-1445. PubMed ID: 38567900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
    McElroy EA; Buckner JC; Lewis JE
    Neurosurgery; 1998 May; 42(5):1023-7; discussion 1027-8. PubMed ID: 9588546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.